.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, Tinctible operated as a single-category brand with Tincture & Sublingual accounting for 100.0% of sales, while category sales declined 67.5% year over year and 43.1% month over month; average price fell 7.7% YoY to $18.43 alongside a MoM mix contraction, indicating both demand and pricing pressure concentrated in one lane. Within Ohio, Tincture & Sublingual placement sat at rank 6, and the one-category exposure means the 100.0% mix amplifies each -67.5% YoY and -43.1% MoM swing, implying concentration risk where volume volatility directly translates to brand-level volatility.
The combination of a 100.0% category mix and a rank of 6 in Ohio positions Tinctible as a mid-pack specialist whose -67.5% YoY and -43.1% MoM declines suggest under-indexing on retention or replenishment versus peers at higher ranks. The 7.7% YoY price reduction to $18.43 without a corresponding category diversification, paired with a 100.0% reliance on Tincture & Sublingual, implies the current pricing move is not offsetting share erosion and that improving rank from 6 will likely require either mix expansion or deeper promotional efficiency rather than further broad price cuts.
Competitive Landscape
Tinctible sits at rank #6 in OH Tincture & Sublingual in May 2026, down 1 position year over year from #5, and flat versus three months ago at #6; the brand’s historical ceiling remains rank #4 last reached in February 2025, indicating a two-rank gap from its peak that has persisted across recent periods. Competitive movement suggests pressure both above and below: Standard Farms advanced from #4 to #3 while posting a 10.45% YoY sales gain, and Avexia climbed from #6 to #4 with 12.57% YoY growth, whereas Doctor Solomon's slid from #3 to #5 with a 36.53% YoY decline, reshuffling the mid-tier around Tinctible. With the category led by UB GOOD holding #1 both this year and last alongside an 18.16% YoY increase, Tinctible’s -1 rank drift and static three-month placement imply a stall-out phase where incremental share is at risk of being absorbed by faster-rising neighbors rather than recaptured from the top two.
Notable Products
Squeeze In- THC/CBG/CBD 2:1:1 Relief Blue Raspberry Gel 11-Pack (110mg THC, 55mg CBG, 55mg CBD) posted the steepest decline at -64.5% month over month and fell to rank 2, while Squeeze In - THC/CBN 3:1 Blueberry Lavender Sleep Gel 11-Pack (110mg THC, 33mg CBN) contracted -17.2% but held rank 1. Squeeze In- CBD/THC 1:1 Spark Watermelon Gel 11-Pack (110mg CBD, 110mg THC) slipped -47.9% and sits at rank 3, and all three top-3 SKUs are Tincture & Sublingual products, indicating a concentrated lineup despite divergent trajectories. With only one SKU growing and two registering double-digit MoM declines above -40%, the pattern implies Tinctible is leaning on a single flagship while broader relief and balanced formulations need repositioning to stabilize category share.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
